Intra-Accumbal Injection of CART (Cocaine-Amphetamine Regulated Transcript) Peptide Reduces Cocaine-Induced Locomotor Activity

Journal of Pharmacology and Experimental Therapeutics

Volumn 307, Issue 3, 2003, Pages 1038-1044

  Jaworski, Jason N ^a   Kozel, Marie A ^a   Philpot, Kelly B ^a   Kuhar, Michael J ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT PEPTIDE; COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT PEPTIDE[1-27]; COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT PEPTIDE[55-102]; DOPAMINE; PEPTIDE FRAGMENT; PSYCHOSTIMULANT AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; DOSE RESPONSE; DRUG ANTAGONISM; INJECTION; LOCOMOTION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT;

ANIMALS; COCAINE; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS; MALE; MOTOR ACTIVITY; NERVE TISSUE PROTEINS; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0344304802     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.052332     Document Type: Article

References (35)

1. Adams LD, Gong W, Vechia SD, Hunter RG, and Kuhar MJ (1999) CART: from gene to function. Brain Res 848:137-140.
2. Bannon AW, Seda J, Carmouche M, Francis JM, Jarosinski MA, and Douglass J (2001) Multiple behavioral effects of cocaine- and amphetamine-regulated transcript (CART) peptides in mice: CART 42-89 and CART 49-89 differ in potency and activity. J Pharmacol Exp Ther 299:1021-1026.
3. Boules M, Warrington L, Fauq A, McCormick D, and Richelson E (2001) A novel neurotensin analog blocks cocaine- and D-amphetamine-induced hyperactivity. Eur J Pharmacol 426:73-76.
4. Brenz Verca MS, Widmer DA, Wagner GC, and Dreyer J (2001) Cocaine-induced expression of the tetraspanin CD81 and its relation to hypothalamic function. Mol Cell Neurosci 17:303-316.
5. Brunetti L, Orlando G, Michelotto B, Recinella L, and Vacca M (2000) Cocaine- and amphetamine-regulated transcript peptide-(55-102) and thyrotropin releasing hormone inhibit hypothalamic dopamine release. Eur J Pharmacol 409:103-107,
6. Couceyro PR and Lambert PD (1999) CART peptides: therapeutic potential in obesity and feeding disorders. Drug News Perspect 12:133-136.
7. Dallvechia-Adams S, Smith Y, and Kuhar MJ (2001) CART peptide-immunoreactive projection from the nucleus accumbens targets substantia nigra pars reticulata neurons in the rat. J Comp Neurol 434:29-39.
8. Douglass J, McKinzie AA, and Couceyro P (1995) PCR differential display identifies a rat brain mRNA that is transcriptionally regulated by cocaine and amphetamine. J Neurosci 15:2471-2481.
9. Ervin GN, Birkemo LS, Nemeroff CB, and Prange AJ Jr (1981) Neurotensin blocks certain amphetamine-induced behaviours. Nature (Lond) 291:73-76.
10. Fagergren P and Hurd YL (1999) Mesolimbic gender differences in peptide CART mRNA expression: effects of cocaine. Neuroreport 10:3449-3452.
11. Hanson GR and Keefe KA (1999) Dopamine D-1 regulation of caudate neurotensin mRNA in the presence or absence of the nigrostriatal dopamine pathway. Brain Res Mol Brain Res 66:111-121.
12. Hurd YL, Svensson P, and Ponten M (1999) The role of dopamine, dynorphin and CART systems in the ventral striatum and amygdala in cocaine abuse. Ann N Y Acad Sci 877:499-506.
13. Jaworski JN, Vicentic A, Hunter RG, Kimmel HL, and Kuhar MJ (2003) CART peptides are modulators of mesolimbic dopamine and psychostimulants. Life Sci 73:741-747.
14. Kalivas PW (1985) Interactions between neuropeptides and dopamine neurons in the ventromedial mesencephalon. Neurosci Biobehav Rev 9:573-587.
15. Kalivas PW, Burgess SK, Nemeroff CB, and Prange AJ Jr (1983) Behavioral and neurochemical effects of neurotensin microinjection into the ventral tegmental area of the rat. Neuroscience 8:495-505.
16. Kalivas PW and Miller JS (1984) Substance P modulation of dopamine in the nucleus accumbens. Neurosci Lett 48:55-59.
17. Kalivas PW, Nemeroff CB, and Prange AJ Jr (1984) Neurotensin microinjection into the nucleus accumbens antagonizes dopamine-induced increase in locomotion and rearing. Neuroscience 11:919-930.
18. Kalivas PW, Richardson-Carlson R, and Duffy P (1986) Neuromedin N mimics the actions of neurotensin in the ventral tegmental area but not in the nucleus accumbens. J Pharmacol Exp Ther 238:1126-1131.
19. Kelley AE and Cador M (1988) Behavioral evidence for differential neuropeptide modulation of the mesolimbic dopamine system. Ann N Y Acad Sci 537:415-434.
20. Kimmel HL, Gong W, Vechia SD, Hunter RG, and Kuhar MJ (2000) Intra-ventral tegmental area injection of rat cocaine and amphetamine-regulated transcript peptide 55-102 induces locomotor activity and promotes conditioned place preference. J Pharmacol Exp Ther 294:784-792.
21. Kimmel HL, Thim L, and Kuhar MJ (2002) Activity of various CART peptides in changing locomotor activity in the rat. Neuropeptides 36:9-12.
22. Koylu EO, Couceyro PR, Lambert PD, and Kuhar MJ (1998) Cocaine- and amphetamine-regulated transcript peptide immunohistochemical localization in the rat brain. J Comp Neurol 391:115-132.
23. Kuhar MJ, Adams LD, Hunter RG, Vechia SD, and Smith Y (2000) CART peptides. Regul Pept 89:1-6.
24. Kuhar MJ and Dall Vechia SE (1999) CART peptides: novel addiction- and feeding-related neuropeptides. Trends Neurosci 22:316-320.
25. Kuhar MJ, Ritz MC, and Boja JW (1991) The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci 14:299-302.
26. Paxinos G and Watson C (1986) The Rat Brain in Stereotaxic Coordinates, 4th ed, Academic Press, New York.
27. Pijnenburg AJ, Honig WM, Van der Heyden JA, and Van Rossum JM (1976) Effects of chemical stimulation of the mesolimbic dopamine system upon locomotor activity. Eur J Pharmacol 35:45-58.
28. Smith Y, Kieval J, Couceyro PR, and Kuhar MJ (1999) CART peptide-immunoreactive neurones in the nucleus accumbens in monkeys: ultrastructural analysis, colocalization studies and synaptic interactions with dopaminergic afferents. J Comp Neurol 407:491-511.
29. Smith Y, Koylu EO, Couceyro P, and Kuhar MJ (1997) Ultrastructural localization of CART (cocaine- and amphetamine-regulated transcript) peptides in the nucleus accumbens of monkeys. Synapse 27:90-94.
30. Steiner H and Gerfen CR (1998) Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior. Exp Brain Res 123:60-76.
31. Swanson CJ, Heath S, Stratford TR, and Kelley AE (1997) Differential behavioral responses to dopaminergic stimulation of nucleus accumbens subregions in the rat. Pharmacol Biochem Behav 58:933-945.
32. Thim L, Kristensen P, Larsen PJ, and Wulff BS (1998a) CART, a new anorectic peptide. Int J Biochem Cell Biol 30:1281-1284.
33. Thim L, Nielsen PF, Judge ME, Andersen AS, Diers I, Egel-Mitani M, and Hastrup S (1998b) Purification and characterisation of a new hypothalamic satiety peptide, cocaine and amphetamine regulated transcript (CART), produced in yeast. FEBS Lett 428:263-268.
34. Vrang N, Larsen PJ, and Kristensen P (2002) Cocaine-amphetamine regulated transcript (CART) expression is not regulated by amphetamine. Neuroreport 13: 1215-1218.
35. Wagstaff JD, Gibb JW, and Hanson GR (1996) Dopamine D2-receptors regulate neurotensin release from nucleus accumbens and striatum as measured by in vivo microdialysis. Brain Res 721:196-203.